Track Entrada Therapeutics's other current assets ($8.9M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), TRDA shows a other current assets of $8.9M. That compares with $15M in the prior-year period — down 41.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, TRDA's other current assets is now $8.9M (was $15M) — a 41.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Entrada Therapeutics is outperforming or lagging.
Tracking TRDA's other current assets over time shows whether Entrada Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $8.9M That compares with $15M in the prior-year period — down 41.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current assets page, Stockcircle has Entrada Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $8.9M) with ownership activity and broader fundamentals.